Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

Summary

Phase I trial to study the effect on the body of combining oxaliplatin with bortezomib in treating patients who have metastatic or unresectable cancer. Drugs used in chemotherapy such as oxaliplatin use different ways to stop cancer cells from dividing so they stop growing or die. Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for tumor cell growth. Combining oxaliplatin with bortezomib may kill more cancer cells

Timeline

Start

2003-07

Primary completion

2007-04

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications